Literature DB >> 17002478

Should we abandon QALYs as a resource allocation tool?

Sandeep Vijan1.   

Abstract

Mesh:

Year:  2006        PMID: 17002478     DOI: 10.2165/00019053-200624100-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

1.  Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

Authors:  Nancy Devlin; David Parkin
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

2.  Quality, innovation, and value for money: NICE and the British National Health Service.

Authors:  Steven D Pearson; Michael D Rawlins
Journal:  JAMA       Date:  2005-11-23       Impact factor: 56.272

3.  QALYs: are they helpful to decision makers?

Authors:  Maurice McGregor; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  The impact of considering adaptation in health state valuation.

Authors:  Laura J Damschroder; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  Soc Sci Med       Date:  2005-01-28       Impact factor: 4.634

  4 in total
  5 in total

1.  Evaluation of benefit-risk.

Authors:  Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  A comparison of the superficial inferior epigastric artery flap and deep inferior epigastric perforator flap in postmastectomy reconstruction: A cost-effectiveness analysis.

Authors:  Achilleas Thoma; Leigh Jansen; Sheila Sprague; Eric Duku P Stat
Journal:  Can J Plast Surg       Date:  2008

3.  The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Authors:  Paul A Scuffham; Jennifer A Whitty; Andrew Mitchell; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Measuring health-related quality of life in drug clinical trials: is it given due importance?

Authors:  Ramón San Miguel; Ana María López-González; Eduardo Sanchez-Iriso; Javier Mar; Juan M Cabasés
Journal:  Pharm World Sci       Date:  2007-08-25

5.  Users' guide to the orthopaedic literature: what is a cost-effectiveness analysis?

Authors:  Stephanie Tanner; Sheila Sprague; Kyle Jeray
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.